R-Tech Ueno


News

News List RSS

June 24, 2015

Annual Securities Report for the Year Ended March 31, 2015

June 23, 2015

Notice Concerning Changes in Corporate Auditor

June 17, 2015

Fiscal Year March 2015 Earnings OverallManagement Indicator: IR report issued by Spring Capital Co., Ltd.

June 17, 2015

"Mid-Term & Long-Term Earnings Growth" Fiscal Year March 2015 Earnings Results WRJ Report: IR report issued by Walden Research Japan Incorporated.

June 8, 2015

Announcement on Collaborative Development of Therapeutic Agent for Cerebral Infarction Utilizing VAP-1 Inhibitor (RTU-009) with Autonomous University of Barcelona and Vall d’Hebron Institute of Research

June 4, 2015

Announcement on Development and Sales Launch of Research Reagent "Human Soluble Form VAP-1 Measurement Kit" utilizing our Monoclonal Antibody

June 1, 2015

Announcement on Start of CSR Activity Linked to the Number of Shareholders and Donation to "NPO Monkey Magic"

May 29, 2015

Presentation Video for the Analyst Meeting (for FY 3/2015) dated of May 21, 2015.
* When the above-mentioned page is not displayed, please have a look by You Tube.

May 25, 2015

Announcement on Completion of the Phase I Single-Dose Clinical Trial for the novel VAP-1 Inhibitor RTU-1096

May 18, 2015

Announcement on Collaborative Development of Therapeutic Agent for Diabetic Retinopathy and Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) with Hokkaido University

May 18, 2015 "Potentials to Expand Region-Wise" Fiscal Year March 2015 Earnings Results WRJ Flash Report: IR report issued by Walden Research Japan Incorporated.

May 14, 2015

R-Tech Ueno Announces Fiscal Year March 2015 Earnings

May 14, 2015 Summary of Business Results for the Year Ended March 31, 2015 [Japan GAAP] (Non-consolidated)

Stock Performance

University Collaborative Research

Our Products

R-Tech Ueno's originally developed Rescula® Eye Drops is a glaucoma/ocular hypertension treatment drug that was the first in the world to utilize Prostone.


Brief

IR E-mail

FAQ

Contact Us


Head Office: NBF Hibiya Bldg., 10F, 1-1-7 Uchisaiwaicho, Chiyoda-ku, Tokyo 100-0011, Japan

Page Top